Flt3 ligand induces tumor regression and antitumor immune responses in vivo

Nature Medicine
D H LynchJ C Schuh

Abstract

Daily treatment of mice with recombinant human Flt3 ligand (huFlt3L) results in a dramatic numerical increase in the number of dendritic cells (DCs) in vivo. Since DCs are pivotal in the induction of immune responses, we tested whether Flt3L treatment of mice challenged with a syngeneic methylcholanthrene (MCA)-induced fibrosarcoma would augment the generation of effective antitumor immune responses in vivo. Flt3L treatment not only induced complete tumor regression in a significant proportion of mice, but also decreased tumor growth rate in the remaining mice. A preliminary characterization of the cellular mechanisms involved suggests that Flt3L may be important in the treatment of cancer in situ through the generation of specific antitumor immune responses.

References

Jan 1, 1991·Annual Review of Immunology·R M Steinman
Oct 11, 1966·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·L Brent, P Medawar
Jan 1, 1995·Annual Review of Immunology·D M Pardoll
Jan 1, 1996·The Journal of Experimental Medicine·C M CelluzziL D Falo
Jan 1, 1996·The Journal of Experimental Medicine·J W Young, K Inaba
Aug 1, 1995·International Journal of Hematology·S D Lyman

❮ Previous
Next ❯

Citations

Mar 30, 2000·International Journal of Cancer. Journal International Du Cancer·G C SpagnoliM Heberer
Jun 8, 2000·International Journal of Cancer. Journal International Du Cancer·N Favre-FelixB Bonnotte
Mar 16, 2007·Cancer Immunology, Immunotherapy : CII·Sheng HouYajun Guo
Mar 11, 2006·International Journal of Colorectal Disease·E RyschichJ Schmidt
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Sandra DemariaSilvia C Formenti
Aug 3, 2001·Vaccine·P MoingeonA Lindberg
Mar 25, 1999·Experimental Hematology·L JinC A Blau
Aug 4, 2001·Pathologie-biologie·C Maliszewski
Sep 28, 2000·Current Opinion in Immunology·R M Dallal, M T Lotze
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Nussey, M L Turner
Jan 25, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L ZitvogelS Amigorena
Mar 20, 2002·Cytokine & Growth Factor Reviews·Ivan Borrello, Drew Pardoll
Aug 28, 1998·Cytokine & Growth Factor Reviews·M R ShurinM T Lotze
Mar 22, 2002·The Lancet Oncology·M JeffordI D Davis
Aug 22, 2002·International Immunopharmacology·R Lee MosleyJames E Talmadge
Sep 3, 2003·Nature Reviews. Cancer·Derek L Stirewalt, Jerald P Radich
Nov 5, 2002·Nature Reviews. Cancer·Mark J SmythHideo Yagita
Jun 10, 2000·British Journal of Haematology·O PfisterA Wodnar-Filipowicz
Dec 8, 1998·The Journal of Experimental Medicine·B PulendranC R Maliszewski
Jan 19, 2002·Journal of Hematotherapy & Stem Cell Research·J VakkilaU M Saarinen-Pihkala
Mar 4, 1998·Journal of Hematotherapy·A J Troy, D N Hart
Jan 26, 2000·The Laryngoscope·G M SprinzlA Schrott-Fischer
Jun 27, 2000·Australian and New Zealand Journal of Medicine·P Hersey
Feb 7, 2001·Journal of Virology·D R DrakeA E Lukacher
Jun 3, 2000·Annual Review of Immunology·L Fong, E G Engleman
Mar 12, 1999·Annual Review of Medicine·J M Timmerman, R Levy
Feb 9, 2012·International Journal of Surgical Oncology·Anthony P TufaroAnne C Fischer
Mar 3, 2004·The Journal of Clinical Investigation·Katsuyoshi FurumotoMiriam Merad
Dec 15, 2007·Neuro-oncology·Gwendalyn D KingMaria G Castro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.